Full Text
Price And Utilization Of New Drugs Under A Single Public Payer System- Evidence From Taiwan

Abstract

Authors

Y LIU CY Lu

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×